183 related articles for article (PubMed ID: 12854132)
1. Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer.
Zheng HC; Sun JM; Wei ZL; Yang XF; Zhang YC; Xin Y
World J Gastroenterol; 2003 Jul; 9(7):1415-20. PubMed ID: 12854132
[TBL] [Abstract][Full Text] [Related]
2. Growth, invasion, metastasis, differentiation, angiogenesis and apoptosis of gastric cancer regulated by expression of PTEN encoding products.
Zheng HC; Li YL; Sun JM; Yang XF; Li XH; Jiang WG; Zhang YC; Xin Y
World J Gastroenterol; 2003 Aug; 9(8):1662-6. PubMed ID: 12918097
[TBL] [Abstract][Full Text] [Related]
3. Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma.
Xu LN; Zou SQ; Wang JM
World J Gastroenterol; 2005 Jun; 11(24):3719-23. PubMed ID: 15968727
[TBL] [Abstract][Full Text] [Related]
4. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
[TBL] [Abstract][Full Text] [Related]
5. Expression of Fas ligand in gastric carcinoma relates to lymph node metastasis.
Nagashima H; Mori M; Sadanaga N; Mashino K; Yoshikawa Y; Sugimachi K
Int J Oncol; 2001 Jun; 18(6):1157-62. PubMed ID: 11351245
[TBL] [Abstract][Full Text] [Related]
6. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
[TBL] [Abstract][Full Text] [Related]
7. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
8. Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma.
Koyama S; Koike N; Adachi S
J Cancer Res Clin Oncol; 2001 Jan; 127(1):20-6. PubMed ID: 11206267
[TBL] [Abstract][Full Text] [Related]
9. Maspin expression and its clinicopathological significance in tumorigenesis and progression of gastric cancer.
Wang MC; Yang YM; Li XH; Dong F; Li Y
World J Gastroenterol; 2004 Mar; 10(5):634-7. PubMed ID: 14991928
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induced by preoperative oral 5'-DFUR administration in gastric adenocarcinoma and its mechanism of action.
Zhao WH; Wang SF; Ding W; Sheng JM; Ma ZM; Teng LS; Wang M; Wu FS; Luo B
World J Gastroenterol; 2006 Mar; 12(9):1356-61. PubMed ID: 16552801
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.
Takahama Y; Yamada Y; Emoto K; Fujimoto H; Takayama T; Ueno M; Uchida H; Hirao S; Mizuno T; Nakajima Y
Gastric Cancer; 2002; 5(2):61-8. PubMed ID: 12111580
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand expression in esophageal carcinomas and their lymph node metastases.
Younes M; Schwartz MR; Ertan A; Finnie D; Younes A
Cancer; 2000 Feb; 88(3):524-8. PubMed ID: 10649242
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
[TBL] [Abstract][Full Text] [Related]
14. [Expression of Fas, FasL and IFN-gamma in gastric cancer].
Li Z; Wang Z; Zhao Z; Zhang Y; Ke Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):386-9. PubMed ID: 12947554
[TBL] [Abstract][Full Text] [Related]
15. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL
J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016
[TBL] [Abstract][Full Text] [Related]
16. The distribution and intracellular location of Fas and Fas Ligand following gastric carcinogenesis: Fas Ligand expressing gastric carcinoma cells can inhibit local immune response.
Liu H; Ubukata H; Tabuchi T; Nakachi T; Nagata H; Shimazaki J; Motohashi G; Konishi S; Nishimura M; Satani T; Hong J; Nakada I; Saniabadi AR; Tabuchi T
Mol Cell Biochem; 2009 Nov; 331(1-2):181-6. PubMed ID: 19458913
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Fas/FasL expression to cell apoptosis in Epstein-Barr virus-associated gastric carcinoma.
He D; Xiao L; Chen JN; Liang Q; Shao CK
Chin J Cancer; 2010 Mar; 29(3):283-7. PubMed ID: 20193111
[TBL] [Abstract][Full Text] [Related]
18. The extrinsic apoptotic signaling pathway in gastric adenocarcinomas assessed by tissue microarray.
Gomes TS; Oshima CT; Segreto HR; Barrazueta LM; Costa HO; Lima FO; Forones NM; Ribeiro DA
Pathol Res Pract; 2011 Oct; 207(10):613-7. PubMed ID: 21856093
[TBL] [Abstract][Full Text] [Related]
19. Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL.
Syed V; Ho SM
Oncogene; 2003 Oct; 22(44):6883-90. PubMed ID: 14534535
[TBL] [Abstract][Full Text] [Related]
20. Fas ligand expression in cervical adenocarcinoma: relevance to lymph node metastasis and tumor progression.
Kase H; Aoki Y; Tanaka K
Gynecol Oncol; 2003 Jul; 90(1):70-4. PubMed ID: 12821344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
